The global inhalation CDMO market is projected to expand from USD 9.13 billion in 2025 to USD 16.68 billion by 2035, reflecting a steady compound annual growth rate (CAGR) of 5.7% over the forecast ...
Among swallowed topical corticosteroids for eosinophilic oesophagitis (EoE), budesonide and fluticasone orodispersible tablets showed superior histologic efficacy, and budesonide inhalation devices ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results